TechFlow news, November 22 — According to PR Newswire, NASDAQ-listed biotechnology company Anixa Biosciences (NASDAQ: ANIX) announced that its board of directors has approved the inclusion of bitcoin as part of the company's treasury reserve assets. CEO Amit Kumar stated that this move is part of prudent financial management aimed at creating greater value for shareholders.
Mike Catelani, President and CFO of Anixa, noted that with the approval of bitcoin ETFs and increasing institutional investor participation, bitcoin has become a mainstream asset class. He emphasized that bitcoin’s unique inflation-resistant characteristics and value preservation potential align with the company’s goals of achieving long-term financial stability and growth.
